title: Rhabdomyolysis and coma associated with amisulpride: a probable atypical presentation of neuroleptic malignant syndrome.
authors.forename: E Cem
authors.initials: EC
authors.lastname: Atbasoglu
authors.forename: Halise Devrimci
authors.initials: HD
authors.lastname: Ozguven
authors.forename: Meram
authors.initials: M
authors.lastname: Can Saka
authors.forename: Ceren
authors.initials: C
authors.lastname: Goker
mesh_terms: D000328:Adult; D000077582:Amisulpride; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003128:Coma / Q000139:chemically induced* / Q000175:diagnosis; D003402:Creatine Kinase / Q000097:blood; D005260:Female; D006801:Humans; D007964:Leukocytosis / Q000175:diagnosis; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis / Q000209:etiology*; D012206:Rhabdomyolysis / Q000139:chemically induced* / Q000175:diagnosis; D012559:Schizophrenia / Q000188:drug therapy*; D013469:Sulpiride / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D014150:Antipsychotic Agents; D013469:Sulpiride; D000077582:Amisulpride; D003402:Creatine Kinase